Neonatal Screening Systems
Neonatal screening is used to detect in babies congenital diseases
that are treatable only when identified during the first days of
life. PerkinElmer supplies all of the products needed to establish
and maintain an effective screening program.
PerkinElmer's Neonatal17 a-OH-Progesterone (17OHP)
assayfor its DELFIA®, AutoDELFIA® and GSP®
High performance, reliable CHscreening toolsThe
analytical sensitivity of PerkinElmer'sNeonatal TSH...
The incidence of galactosemia is 1:14000 - 1:60000. The untreated
disorder will cause poor development,...
Top performance based onrobust DELFIA® chemistry
The Neonatal IRT assay provides high analytical sensitivity...
PerkinElmer supplies neonatal kits for the quantitative determination of TREC (T-cell receptor excision...
PerkinElmer platforms for dried blood spot assays include the GSP Genetic Screening Processor and the...